New recommendations for testing C-reactive protein (CRP) will change the way you assess cardiovascular risk
New recommendations for testing C-reactive protein (CRP) will change the way you assess cardiovascular risk.
Traditional CRP tests are useful to diagnose rheumatoid arthritis, lupus, and other inflammatory diseases.
Now high-sensitivity CRP (hs-CRP) tests are recommended by the American Heart Assoc and CDC to help predict cardiovascular risk.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: PA includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote